- Co-generation unit promotes climate protection and energy efficiency
- To manufacture vitamin preparations, industrial and laboratory chemicals as well as microbiological products, among others
Goa/Mumbai, November 25, 2014 – Merck, a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life science sectors, today commissioned a climate-neutral co-generation plant at its production site in Goa, India.
In doing so, Merck is underscoring its commitment to climate protection and energy efficiency in line with its corporate responsibility. The project is part of a company-wide climate protection program. Merck previously commissioned a new co-generation plant at its headquarters in Darmstadt in July.
Dr. Thierry Hulot, Executive Vice President, Head of Global Manufacturing & Supply and Member of Merck Pharmaceutical Executive Committee visited India on the occasion and inaugurated the plant. He said, “Merck’s new climate-neutral co-generation plant in Goa has a tremendous power output for our pharmaceutical and chemical production operations. In the manufacture of our products, we seek to impact the environment as little as possible. As a responsible company, we express our respect to the environment in an Industrial Plant that provides medicines for millions of patients in India.”
Merck’s Goa site is located in Usgao, around 45 kilometers from Panaji, the capital of the Indian state of Goa. This co-generation unit, which has a power output of three megawatts, generates electricity and steam for the pharmaceutical and chemical production operations in Goa. Merck is mainly recycling the shells of cashews and coconuts, two crops that are farmed in the region, to use as biomass. Overall, this will make it possible to reduce carbon dioxide emissions by around 11,500 metrics tons, corresponding to around 85% of the site’s total CO2 emissions. The biomass plant, which represents an investment of more than € 3 million, will ensure that the site has a reliable supply of energy and can operate independently of the public power grid. More than 300 employees manufacture vitamin preparations, industrial and laboratory chemicals as well as microbiological products, among other things.
Speaking on the occasion, Mr. Pramod Pimplikar, Director – Technical Operations, GMS- Merck Serono said, “We are extremely excited in being able to make a positive difference to our business, the environment and capacity building efforts. With this Green field site, we aim to reduce CO2 emission by 85% and deliver clean, green, efficient, reliable power and steam supply, improving efficiencies and contributing to the nation’s interest. By 2020 Merck KGaA has committed to reduce its global CO2 emissions by 20% and we are happy to be in a position to contribute to those efforts.”
The climate protection program Edison comprises around 300 climate protection and energy efficiency activities of the Merck Group. The objective is to reduce greenhouse gas emissions from energy generation as well as to enhance the energy efficiency of research and production processes. Merck aims to reduce its total direct and indirect greenhouse gas emissions by 20% by 2020, measured against the 2006 baseline. At its site in Jaffrey, New Hampshire (USA), Merck plans to commission a further biomass central heating plan next year.
Merck is a leading company for innovative, top-quality high-tech products in the chemical, pharmaceutical and life science sectors. With its four divisions Merck Serono, Consumer Health, Performance Materials and Merck Millipore, Merck generated total revenues of around € 11.1 billion in 2013. Around 39,000 employees work for Merck in 66 countries to improve the quality of life for patients, to further the success of customers, and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company is known as EMD.